Evaluation of the frequency of limitation of activity in patients with persistent asthma - ASMAVIE
Study identifier:NIS-RFR-DUM-2009/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Evaluation of the frequency of limitation of activity, depending on gender and age-group, in patients with persistent asthma consulting a general practitioner
Medical condition
persistent asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1942
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Mar 2010
Primary Completion Date: 01 Oct 2010
Study Completion Date: 01 Oct 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Pascal Piedbois
AstraZeneca
